MARLBOROUGH, Mass.,
Nov. 7, 2018 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) will participate
in the 2018 Canaccord Genuity Medical Technologies &
Diagnostics Forum on Thursday, November 15,
2018 in New York City.
David Pierce, executive vice
president and president, MedSurg and Susie
Lisa, vice president, Investor Relations, will participate
in a 60-minute roundtable discussion session with the host analyst
beginning at approximately 9:30 a.m.
EST. A live webcast of the session will be available
on the Investor Relations section of the Boston Scientific website
at investors.bostonscientific.com.
A replay of the webcast will be accessible at
investors.bostonscientific.comhttp://www.bostonscientific.com/investors
beginning approximately one hour following the completion of the
event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for more than 35 years, we advance science for life by
providing a broad range of high performance solutions that address
unmet patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Kate
Haranis
|
Susie Lisa,
CFA
|
508-683-6585
(office)
|
508-683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Kate.Haranis@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original
content:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-2018-canaccord-genuity-medical-technologies--diagnostics-forum-300745456.html
SOURCE Boston Scientific Corporation